After completing the pre-screener and providing consent to be referred, DecenTrialz securely transmits your information to the clinical research team associated with the matched study. This section outlines how that contact process works, who may reach out to you, and what to expect during this early phase of communication.

Who will contact you and why?

Following referral, the research site — which may be a hospital, clinic, academic medical center, or independent research facility — becomes responsible for initiating direct communication. While some sites may be affiliated with a study sponsor (e.g., a pharmaceutical or biotechnology company), you will only be contacted by the site staff or their designated personnel.

You may be contacted by:

• A Clinical Research Coordinator (CRC)
• A Research Nurse
• A Participant Recruitment or Engagement Specialist

Their role is to begin the official screening process, confirm your interest, provide study details, and respond to your questions.

How will they contact you?

The research site team will use the preferred contact method you selected during pre-screening. This may include:

• Phone call
• Email communication
• Text message, if you explicitly consented to that method

In their initial outreach, they may reference:

• The study title
• The name of the research site or principal investigator
• That you expressed interest via the DecenTrialz platform

Note: You will not be contacted unless you have explicitly consented to referral.

What Information will the research site receive?

The information shared with the research site is limited to:

• Your name and contact details
• Your pre-screener responses
• Any communication preferences you provided (e.g., best times to reach you)

The research site will not receive:

• Your complete medical history or records
• Insurance or billing information
• Any unrelated personal data

What to expect during initial contact

During their first communication with you, the research site team may:

• Confirm that you remain interested in the study
• Ask follow-up questions to assess your eligibility
• Provide an overview of the study purpose, procedures, and timelines
• Offer to schedule a screening appointment or virtual consultation
• Share additional materials, such as the informed consent form or reimbursement policy

This is also your opportunity to ask questions about the trial, your rights as a participant, and what the study involves.

Key Note: Once you are referred, DecenTrialz no longer participates in the communication process. All further discussions occur directly between you and the research site. You are under no obligation to respond or move forward. You may withdraw your interest at any time, and the research site is ethically required to respect your privacy and decision without pressure.